Author

Ulrike Babilonski

Institutions: Idorsia (Switzerland), Idorsia Pharmaceuticals Ltd (Switzerland)

Observed institutions: Idorsia (Switzerland), Idorsia Pharmaceuticals Ltd (Switzerland)

OpenAlex ID: A5116852003

Efficacy of IDOR‐1117‐2520, a novel, orally available CCR6 antagonist in preclinical models of skin dermatitis

2025 · Paulina Kulig, Pijus Brazauskas, et al. · British Journal of Pharmacology · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: